Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Colon Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00003485
What this trial is testing

Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer

Who this might be right for
Colon Cancer
Burzynski Research Institute 15
Large-scale testing (Phase 3)Study completedNCT00008060
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Medical Research Council
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642
What this trial is testing

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

Who this might be right for
Uterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more
GV20 Therapeutics 227
Testing effectiveness (Phase 2)UnknownNCT05799820
What this trial is testing

QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC

Who this might be right for
Colorectal Carcinoma
Qilu Pharmaceutical Co., Ltd. 60
Large-scale testing (Phase 3)Ended earlyNCT00387348
What this trial is testing

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerDepressionEsophageal Cancer+7 more
Massachusetts General Hospital 24
Early research (Phase 1)Study completedNCT00972036
What this trial is testing

Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy

Who this might be right for
Colon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 32
Not applicableLooking for participantsNCT07776353
What this trial is testing

Understanding New Cachexia Subtypes Through Observational Epidemiological Research

Who this might be right for
Advanced Colorectal CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Pancreatic Adenocarcinoma+5 more
Kaiser Permanente 800
Early research (Phase 1)Active Not RecruitingNCT05848739
What this trial is testing

A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors

Who this might be right for
Colon CancerMetastatic Colon Cancer
Sapience Therapeutics 130
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Large-scale testing (Phase 3)UnknownNCT04525326
What this trial is testing

Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 584
Early research (Phase 1)Active Not RecruitingNCT05907304
What this trial is testing

Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

Who this might be right for
Advanced or Metastatic Solid Tumors
Erasca, Inc. 86
Large-scale testing (Phase 3)Looking for participantsNCT05863195
What this trial is testing

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverStage IV Colorectal Cancer AJCC v8+1 more
ECOG-ACRIN Cancer Research Group 408
Testing effectiveness (Phase 2)Looking for participantsNCT05742425
What this trial is testing

Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases

Who this might be right for
Unresectable Colon Cancer Peritoneal MetastasesPMMR/Ras/BRAF Wild-type
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT03050814
What this trial is testing

Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004

Who this might be right for
Colorectal TumorsColorectal NeoplasmsColorectal Carcinoma+2 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT05091346
What this trial is testing

E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors

Who this might be right for
MelanomaCarcinoma, HepatocellularColorectal Neoplasms
Eisai Inc. 89
Early research (Phase 1)Study completedNCT00138177
What this trial is testing

Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage III Colon Cancer+4 more
National Cancer Institute (NCI) 54
Next Page